Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review found that the current evidence on using platelet rich plasma to treat non-cicatricial alopecia, such as androgenetic alopecia and alopecia areata, is of low quality and yields controversial results.

This Mendelian randomization study found that specific dietary patterns, such as consuming antioxidant-rich foods like melon and tea, may have protective effects against hair loss, while processed carbohydrates, alcohol, and certain dairy products could increase the risk of androgenetic alopecia and alopecia areata.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Trichoscopy is a useful tool for diagnosing hair and scalp disorders.

This study found that clinical examination is effective for diagnosing certain non-scarring hair loss types in women, although histopathologic studies are necessary for exact diagnoses, and laboratory tests did not correlate well with clinical findings.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

This review discusses histologic findings in alopecia and emphasizes the importance of understanding normal follicular anatomy and cycles in transverse sections, without reporting new results.

This review examines the various potential causes of bitemporal hair loss, emphasizing the importance of prompt diagnosis to prevent further hair loss in scarring conditions; it reports no new clinical results.

This study reports that nonscarring diffuse hair loss in women is most common in the 21-40 age group, with low serum ferritin, vitamin B12, and vitamin D3 levels contributing to its pathogenesis.

This study observed that non-scarring diffuse hair loss was common in systemic lupus erythematosus patients, but did not find a significant relationship with the SLE Disease Activity Index.

This study observed an association between body iron levels and non-scarring diffuse hair loss in non-menopausal women.

This letter to the editor discusses a previous clinical and histopathological analysis of four cases of severe diffuse non-scarring hair loss in systemic lupus erythematosus, reporting no new study results.

This article highlights the prevalence of iron deficiency, with or without anemia, as a significant factor in diffuse nonscarring hair loss in women, particularly affecting certain groups such as menstruating women and vegetarians.

This article discusses the evaluation and management of common nonscarring hair loss conditions and reports no new clinical results.

This article discusses objective methods for assessing hair loss and notes that most types of hair loss can regrow without treatment, but effective treatments for pattern or senescent alopecia remain unavailable.

In this study, severe diffuse hair loss in patients with systemic lupus erythematosus was associated with distinct clinical, dermoscopic, and histopathological features, which improved alongside treatment of the underlying condition.

This study found that the reticulocyte hemoglobin content (CHr) most frequently indicated iron deficiency in female patients with diffuse non-scarring hair loss.

Among female patients experiencing hair loss, this study found telogen effluvium to be the most common type, significantly linked to low ferritin levels, while traction alopecia was more prevalent among those wearing headscarves.

This review examines the hormonal causes of hair loss, noting how androgen excess can lead to follicle miniaturization and linking estrogen deficiency and thyroid dysfunction to common alopecia types. It further discusses hormonal treatments such as finasteride, dutasteride, and spironolactone.

This article reviews the structure and function of hair follicles, diagnostic approaches, and treatments for nonscarring alopecias, but reports no new clinical results.

This case report describes a one-year-old boy with combined occipito-linear and triangular fronto-temporo-parietal alopecia and discusses the possibility of these lesions being a variant of neonatal occipital alopecia.

This study found that VEGF growth factor plays a significant role in the development of androgenetic alopecia and telogen hair loss in women, more so than KGF, TGF-01, or EGF.

Trichoscopy helps diagnose and manage different types of hair loss effectively.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

This review suggests that decreased serum 25-hydroxyvitamin D levels may play a role in different types of non-scarring alopecia, but further studies are needed to explore vitamin D supplementation as a therapeutic option.

This paper reviews hair loss associated with various endocrine disorders and describes both traditional and emerging non-invasive diagnostic methods without presenting any new clinical results.

This study observed similar D2-40 expression in scarring and nonscarring alopecia, with some increase in scarring cases, suggesting possible Fos-dependent mechanisms, though more research is needed for definitive conclusions.

This continuing medical education article outlines the comprehensive approach needed to diagnose alopecia, emphasizing the importance of a thorough history, scalp and hair examination, and, if necessary, laboratory analysis and biopsy for effective treatment planning.

This case report describes the diagnosis and treatment challenges of Graham-Little syndrome, a rare condition involving cicatricial alopecia on the scalp, non-scarring hair loss in certain areas, and keratosis pilaris-like eruptions.

This study found that glucagon-like peptide-1 receptor agonist therapy was independently associated with an increased incidence of non-scarring hair loss, including telogen effluvium and androgenic alopecia, in adults but not alopecia areata.